Table 2.
CV risk factors | IA (n=2050) | RA (n=1308) | PsA (n=356) | SpA (n=386) | Controls (n=939) |
BMI | 25.3 (22.8–28.4) | 25.3 (22.6–28.7) | 26.3 (23.5–29.4) | 24.8 (23.0–27.7) | 24.4 (22.1–17.7) |
Smoking status | |||||
Current, >1×/week | 197 (10) | 136 (10) | 21 (6) | 40 (10) | 49 (5) |
Current, <1×/week | 58 (3) | 31 (2) | 8 (2) | 19 (5) | 22 (2) |
Quit | 925 (45) | 599 (46) | 166 (47) | 160 (42) | 379 (40) |
Never | 716 (35) | 442 (34) | 136 (38) | 138 (36) | 411 (44) |
Alcohol | |||||
Yes | 1165 (57) | 719 (55) | 215 (60) | 231 (60) | 669 (71) |
Incidental | 442 (22) | 288 (22) | 66 (19) | 88 (23) | 170 (18) |
Never | 386 (19) | 263 (20) | 62 (17) | 61 (16) | 82 (9) |
Exercise (min/week) | 420 (211–720) | 420 (181–740) | 420 (220–660) | 390 (210–653) | 490 (220–660) |
<30 min/day | 534 (26) | 359 (27) | 83 (23) | 92 (24) | 160 (17) |
30–60 min/day | 535 (26) | 314 (24) | 103 (29) | 118 (31) | 247 (26) |
>60 min/day | 981 (48) | 635 (49) | 170 (48) | 176 (46) | 532 (57) |
Hypertension | 770 (38) | 496 (38) | 140 (39) | 134 (35) | 231 (25) |
Antihypertensives | 411 (20) | 268 (21) | 80 (23) | 63 (16) | 131 (14) |
Dyslipidaemia | 641 (31) | 422 (32) | 110 (31) | 109 (28) | 207 (22) |
Lipid-lowering medication | 335 (16) | 222 (17) | 59 (17) | 54 (14) | 98 (10) |
Diabetes mellitus | 109 (5) | 67 (5) | 26 (7) | 16 (4) | 13 (1) |
Antidiabetics | 46 (2) | 28 (2) | 10 (3) | 8 (2) | 6 (1) |
Anticoagulants | 246 (12) | 179 (14) | 34 (10) | 33 (9) | 74 (8) |
Data are reported as mean±SD, median (inner quartiles) or frequency (percentage) where appropriate.
BMI, body mass index; CV, cardiovascular ; IA, inflammatory arthritis; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, (axial) spondyloarthritis.